Mxd1’s function as a TS in vivo was initially tested in a study that knocked out the gene in mice and found there to be no significant increase in spontaneous cancer incidence or other major phenotypes, thereby implying that other members of the Mxd family (Figure 1) were functionally redundant [48,49]. The gene discussed is MXD1; the disease is cancer.